Rare Cutaneous Tumors: High-Risk Clues and Treatment Advances

Rare cutaneous tumors can be easy to miss but may carry significant morbidity or mortality when diagnosis is delayed. This session reviews high-risk clinical clues, diagnostic pathways, staging considerations, and treatment advances for uncommon skin cancers and adnexal tumors. Emphasis will be placed on recognizing when a lesion does not fit routine patterns, when to escalate evaluation, and how multidisciplinary care shapes outcomes.